We are live on ! Find out more
MGNX icon

MacroGenics
MGNX

130 hedge funds and large institutions have $789M invested in MacroGenics in 2018 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 43 increasing their positions, 42 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

25% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 12

2% more funds holding

Funds holding: 127 → 130 (+3)

2% more repeat investments, than reductions

Existing positions increased: 43 | Existing positions reduced: 42

0% more funds holding in top 10

Funds holding in top 10: 4 → 4 (0)

1% less capital invested

Capital invested by funds: $794M → $789M (-$5M)

4.01% less ownership

Funds ownership: 91.1% → 87.1% (-4%)

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $212K

Holders
130
Holders Change
+3
Holders Change %
+2.36%
% of All Funds
2.97%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.09%
New
15
Increased
43
Reduced
42
Closed
12
Calls
–
Puts
$212K
Net Calls
-$212K
Net Calls Change
-$312K

Top Buyers

Rank Fund Capital Flow
1
BB
BB Biotech
Switzerland
+$7.03M
2
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$6.26M
3
CS
Candriam SCA
Luxembourg
+$5.65M
4
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale
Germany
+$3.74M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$3.54M

Top Sellers

Rank Fund Capital Flow
1
BC
Boxer Capital
California
-$25.7M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$8.97M
3
AH
Aviva Holdings
Bahamas
-$6.66M
4
Invesco
Invesco
Georgia
-$6.25M
5
State Street
State Street
Massachusetts
-$5.93M
Name Holding Trade Value Shares
Change 		Change in
Stake
6CM
26
683 Capital Management
New York
$7.2M +$1.56M +73,034 +28%
SIM
27
Spark Investment Management
New York
$6.19M -$1.93M -90,300 -24%
RSCM
28
Rock Springs Capital Management
Maryland
$5.9M – – –
GIM
29
Granahan Investment Management
Massachusetts
$5.29M +$148K +6,925 +3%
Charles Schwab
30
Charles Schwab
California
$5.29M +$444K +20,845 +9%
Millennium Management
31
Millennium Management
New York
$4.87M -$4.23M -198,241 -47%
Goldman Sachs
32
Goldman Sachs
New York
$4.67M +$1.78M +83,437 +62%
DekaBank Deutsche Girozentrale
33
DekaBank Deutsche Girozentrale
Germany
$4.33M +$3.74M +175,500 +970%
TCIM
34
TIAA CREF Investment Management
New York
$3.53M -$127K -5,969 -3%
Bank of New York Mellon
35
Bank of New York Mellon
New York
$3.46M +$15.2K +712 +0.4%
Renaissance Technologies
36
Renaissance Technologies
New York
$3.41M -$2.42M -113,376 -42%
Principal Financial Group
37
Principal Financial Group
Iowa
$3.39M +$87.1K +4,084 +3%
EAM
38
Eventide Asset Management
Massachusetts
$3.15M – – –
Jacobs Levy Equity Management
39
Jacobs Levy Equity Management
New Jersey
$2.96M -$241K -11,304 -8%
Deutsche Bank
40
Deutsche Bank
Germany
$2.76M +$286K +13,437 +12%
Morgan Stanley
41
Morgan Stanley
New York
$2.46M +$146K +6,842 +6%
Victory Capital Management
42
Victory Capital Management
Texas
$2.27M -$1.31M -61,400 -37%
Allianz Asset Management
43
Allianz Asset Management
Germany
$2.24M +$188K +8,824 +9%
VIA
44
Vident Investment Advisory
Georgia
$2.24M -$148K -6,963 -6%
OAM
45
Oxford Asset Management
United Kingdom
$1.92M +$930K +43,633 +95%
Macquarie Group
46
Macquarie Group
Australia
$1.72M – – –
TA
47
Teachers Advisors
New York
$1.69M +$213K +9,991 +14%
DCM
48
DAFNA Capital Management
California
$1.68M – – –
Los Angeles Capital Management
49
Los Angeles Capital Management
California
$1.63M +$986K +46,270 +156%
Axa
50
Axa
France
$1.61M +$1.19M +55,874 +291%
1
2
3 4 5

MGNX Hedge Fund Activity: Q3 2018 in Review

130 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in MacroGenics (MGNX) for Q3 2018, worth a combined $789M — down 0.63% from $794M a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new MGNX positions and 12 closed out — a net gain of 3 holders — while 43 added to existing stakes and 42 trimmed.

The largest buyer was BB Biotech, adding an estimated $7.03M. The largest seller was Boxer Capital, exiting entirely with an estimated $25.7M sold.

  • 130 institutional investors held MacroGenics (MGNX) as of Q3 2018, up from 127 in Q2 2018.
  • Funds reported $789M of MacroGenics stock for Q3 2018, down 0.63% quarter-over-quarter.
  • 15 funds opened new MacroGenics positions in Q3 2018 and 12 closed out, a net change of +3 holders.
  • The largest MacroGenics buyer in Q3 2018 was BB Biotech, an estimated $7.03M added.
  • The largest MacroGenics seller in Q3 2018 was Boxer Capital, an estimated $25.7M sold.

Based on aggregated 13F filings for Q3 2018.